Orion Portfolio Solutions’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.12M Sell
84,689
-9,593
-10% -$132K 0.01% 1021
2024
Q4
$1.49M Sell
94,282
-8,338
-8% -$125K 0.01% 839
2024
Q3
$1.63M Buy
102,620
+30,960
+43% +$498K 0.02% 795
2024
Q2
$1.09M Sell
71,660
-2,590
-3% -$37.1K 0.01% 948
2024
Q1
$1.09M Buy
74,250
+1,590
+2% +$23.2K 0.01% 949
2023
Q4
$1.02M Buy
72,660
+34,230
+89% +$458K 0.01% 934
2023
Q3
$514K Sell
38,430
-620
-2% -$8.39K 0.01% 1195
2023
Q2
$493K Sell
39,050
-56,825
-59% -$663K 0.01% 1214
2023
Q1
$1.09M Buy
+95,875
New +$1.03M 0.01% 835

Other funds holding RDY

Orion Portfolio Solutions's RDY Position: Q1 2025 in Review

Orion Portfolio Solutions reduced its Dr. Reddy's Laboratories (RDY) stake by 10% in Q1 2025, selling an estimated $132K and leaving 84,689 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #1021.

Orion Portfolio Solutions first reported a position in RDY in Q1 2023 and has held it in 9 quarters since. The position peaked at $1.63M in Q3 2024. 244 funds tracked by Wall St. Rank hold RDY as of Q1 2025.

  • Orion Portfolio Solutions held 84,689 shares of Dr. Reddy's Laboratories worth $1.12M as of Q1 2025.
  • Orion Portfolio Solutions sold 9,593 Dr. Reddy's Laboratories shares in Q1 2025, an estimated $132K.
  • Dr. Reddy's Laboratories made up 0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #1021 holding.
  • Orion Portfolio Solutions first reported a position in Dr. Reddy's Laboratories in Q1 2023 and has held it in 9 quarters since.
  • Orion Portfolio Solutions's Dr. Reddy's Laboratories position peaked at $1.63M in Q3 2024.
  • 244 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.